tiprankstipranks
Trending News
More News >

Is This the Perfect Biotech Stock for Your Recession Portfolio?

Is This the Perfect Biotech Stock for Your Recession Portfolio?

Biotech stocks are generally extremely volatile, and the ARK Genomic Revolution ETF (ARKG) proves it. The biotech-heavy fund has declined more than 50% year-to-date, compared to the S&P 500 (SPX), which has dropped 20% year-to-date. However, not all biotech stocks are highly volatile. In this video, we look at a particular biotech stock that could add stability to your portfolio in a recession. The company has many FDA-approved products and numerous product candidates in the pipeline. It has a huge cash reserve, putting it in a position to continue to fund the development of its products.

Disclaimer & DisclosureReport an Issue